Antiphospholipid antibodies and vitamin D deficiency in COVID-19 infection with and without venous or arterial thrombosis: A pilot case-control study정맥 또는 동맥 혈전증이 있거나 없는 COVID-19 감염의 항인지질 항체 및 비타민 D 결핍: 파일럿 사례 대조 연구Article Published on 2022-07-142022-09-12 Journal: PLoS ONE [Category] MERS, 진단, [키워드] antibody Anticoagulant anticoagulation antiphospholipid antibody Autoimmune disorders case-control study Chronic kidney disease Control COVID-19 COVID-19 infection COVID-19 patient deficiency Effect End-stage renal disease enrolled evaluate Future hospitalized COVID-19 patient hospitalized COVID-19 patients in both groups malignancy measure mechanisms Myocardial infarction Patient positive reducing Sex significantly more stroke syndrome therapy Thromboembolic event Thromboembolic events Thromboembolism thrombosis venous vitamin D deficiency vitamin D level were excluded were measured [DOI] 10.1371/journal.pone.0269466 PMC 바로가기 [Article Type] Article
Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccinationCOVID-19 및 COVID-19 백신 접종 후의 혈전증 및 혈소판 감소증Review Published on 2022-07-012022-09-11 Journal: Trends in cardiovascular medicine [Category] COVID19(2023년), SARS, 치료기술, [키워드] ACE2 activate Activation acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adaptive immune system Adenovirus Adenovirus-vectored vaccine administration aggregation angiotensin angiotensin converting enzyme angiotensin converting enzyme 2 Antibody detection Antiplatelet factor cause Coagulation Coagulopathy condition coronavirus coronavirus disease COVID-19 COVID-19 vaccination Critical detect diagnosing Diagnosis Disease progression disease severity dysregulation effective ELISA enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay event false-positive rate false-positive rates hemophagocytic lymphohistiocytosis hemophagocytic syndrome immune Immune thrombocytopenic purpura Inflammation initial Interaction lupus erythematosus Messenger RNA mitigate occur optical optical density Pathogenesis PF4 Platelet platelet aggregation Platelets positive progression purpura SARS-CoV-2 serious complication severe acute respiratory syndrome Coronavirus Side effects Spike protein syndrome systemic lupus erythematosus the disease the patient thrombocytopenia thrombocytopenic purpura Thromboembolism thrombosis thrombotic Thrombotic thrombocytopenia Thrombotic thrombocytopenic purpura vaccination Vaccine Vaccines vectored vaccine [DOI] 10.1016/j.tcm.2022.02.008 PMC 바로가기 [Article Type] Review
Lipocalin-2, S100A8/A9, and cystatin C: Potential predictive biomarkers of cardiovascular complications in COVID-19Article Published on 2022-07-012023-07-08 Journal: Experimental Biology and Medicine [Category] COVID19(2023년), [키워드] calprotectin cardiovascular COVID-19 cystatin C lipocalin-2 Thromboembolism [DOI] 10.1177/15353702221091990 PMC 바로가기
Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections백신 접종 후 SARS-CoV-2 감염의 6개월 후유증: 10,024명의 돌발 감염에 대한 후향적 코호트 연구Article Published on 2022-07-012022-09-11 Journal: Brain, behavior, and immunity [Category] COVID19(2023년), SARS, 변종, [키워드] age Anxiety approved association Bonferroni-corrected Bonferroni-corrected p Breakthrough infection Cohort studies competing composite endpoint contribute controls COVID-19 COVID-19 illness COVID-19 outcomes COVID-19 vaccination COVID-19 vaccine death disease disorder dose effective Electronic health record Electronic health records Features Hair loss Health highlight hospitalisation hypoxaemia ICD-10 ICU admission identify Impact incidence individual infection with SARS-CoV-2 Influenza influenza vaccine Intervention intubation long-COVID lower risk mood omicron Omicron variant outcome outcomes oxygen Oxygen requirement Patient Propensity score psychotic disorder public health recorded renal renal disease representing Respiratory failure retrospective cohort study risk robust SARS-CoV-2 SARS-COV-2 infection Seizures significantly lower sleep disorders Thromboembolism time-to-event analysis USA vaccinated individual vaccination Vaccine vaccine dose vaccine doses variant Venous Thromboembolism Ventilation were assessed [DOI] 10.1016/j.bbi.2022.04.013 PMC 바로가기 [Article Type] Article
COVID-19 and venous thromboembolism risk in patients with sickle cell diseaseShort communication Published on 2022-06-272022-10-05 Journal: Blood advances [Category] 진단, [키워드] adjusted adjusted relative risk baseline characteristics causes Cell confidence interval COVID-19 COVID-19 infection disease group Health Hospitalization Hospitalized increase life-threatening log multisite no significant difference Patient patients hospitalized Poisson regression model Research risk risk ratio robust SCD severe COVID-19 illness Severe COVID-19 Infection Thromboembolism Venous Thromboembolism VTE VTE risk with COVID-19 [DOI] 10.1182/bloodadvances.2022007219 [Article Type] Short communication
Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective studyObservational Study Published on 2022-06-212022-10-05 Journal: PLoS Medicine [Category] COVID19(2023년), SARS, 임상, [키워드] 95% CI Administered Adverse adverse event AESI AESIs all-cause mortality Analysis anaphylaxis authority Bell BNT162b2 Characteristics cohort study comparable CoronaVac coronavirus disease country COVID-19 COVID-19 vaccine COVID-19 vaccines cumulative disorder dose electronic medical record event Evidence first dose Follow-up group help Hong Kong inactivated Inactivated vaccine incidence incidence rate include individual individuals limitation Mortality mRNA mRNA vaccines mRNA-based vaccine no significant difference observation period of BNT162b2 Poisson regression models population-based cohort populations rate ratio recipient recipients recorded reduce reported residual confounding retrospective Retrospective study Safety safety profile SARS-CoV-2 vaccine SARS-CoV-2 vaccines second dose significantly higher Surveillance the vaccine Thromboembolism vaccinated individual vaccination Vaccine Vaccine hesitancy Weighting were excluded [DOI] 10.1371/journal.pmed.1004018 PMC 바로가기 [Article Type] Observational Study
COVID-19 Related Thrombotic Complications Experience Before and During Delta Wave.Research article Published on 2022-06-012022-10-05 Journal: Journal of vascular surgery [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] 95% CI 95% confidence interval active malignancy acute respiratory syndrome African American Analysis analyzed anticoagulation association body mass index caused Comorbidities Complication complications Computed tomography coronavirus Coronavirus disease 2019 COVID-19 COVID-19 Delta variant COVID-19 infection Delta delta variant demographic characteristics Diagnosis disease elevated evidenced experience Factor Gender group higher risk highlight hypercoagulable immunosuppressed patient increased risk infected with COVID-19 information Jypercoagulable state less marker objective Odds ratio pathophysiology Patient patients patients with COVID-19 positive Positive test Prevent prothrombotic reported Result retrospective risk risk factor SARS-CoV-2 significantly study cohort subject Thromboembolism thrombosis thrombotic thrombotic complication thrombotic event Thrombotic events vaccination variants of concern venous was performed Wave with COVID-19 [DOI] 10.1016/j.jvs.2022.04.053 [Article Type] Research article
SARS-CoV-2 Positivity in Ambulatory Symptomatic Patients Is Not Associated With Increased Venous or Arterial Thrombotic Events in the Subsequent 30 DaysArticle Published on 2022-06-012023-07-08 Journal: The Journal of emergency medicine [Category] COVID19(2023년), [키워드] COVID-19 Critical care SARS-CoV-2 Thromboembolism thrombosis venous [DOI] 10.1016/j.jemermed.2021.12.020 PMC 바로가기
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19ADAMTS13 희귀 변이의 보균자는 생명을 위협하는 COVID-19의 위험이 높습니다Article Published on 2022-05-292022-09-11 Journal: Viruses [Category] COVID19(2023년), SARS, 변종, [키워드] ADAMTS13 Add-on therapy age aggregation Analysis Asymptomatic autosomal dominant autosomal dominant disorder autosomal recessive autosomal recessive disorder binding caplacizumab carrier carriers characterized cleaving Cohort conditioned congenital COVID-19 COVID-19 severity crizanlizumab disintegrin disorder drug enzyme Families GEN-COVID genetic determinant heterozygous state Host hyper-inflammation infections inhibit inhibiting Interaction large vessel leukocyte ligands motif P-selectin Platelet platelet aggregation Prevent recruitment reported SARS-CoV-2 infected subject SARS-COV-2 infection selectin Sex susceptibility thrombocytopenic purpura Thromboembolism thrombosis thrombotic thrombotic microangiopathy Thrombotic thrombocytopenic purpura triggered variant Vascular damage [DOI] 10.3390/v14061185 PMC 바로가기 [Article Type] Article
Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort studyResearch article Published on 2022-05-132022-10-05 Journal: The Lancet. Infectious Diseases [Category] COVID19(2023년), SARS, 진단, [키워드] adjusted adjusted hazard ratio age association calculate cohort study conducted COVID-19 COVID-19 case COVID-19 cases cumulative database death diagnosis of COVID-19 effective estimate European European Medicines Agency event events fatality finding Frequency funding Germany Hospital admissions hospitalisation hospitalised Hospitalised patients HRs incidence increased risk Italy males Mortality Netherlands Occurrence participant Patient patients with COVID-19 positive RT-PCR primary care ranged reduce Research rising risk SARS-CoV-2 Spain Spanish study outcome study outcomes Thromboembolic events Thromboembolism thrombosis treatment strategy venous thromboembolic Venous Thromboembolism were used with COVID-19 [DOI] 10.1016/S1473-3099(22)00223-7 [Article Type] Research article